Reply: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial

No AccessJournal of UrologyReply to Letters to the Editor6 Mar 2024Reply: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial Landon TrostMD Landon TrostLandon Trost View All Author Informationhttps://doi.org/10.1097/JU.0000000000003896AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail REFERENCES 1. . Comparison of collagenase Clostridium histolyticum to surgery for the management of Peyronie's disease: a randomized trial. J Urol.2023; 210(5):791-802. Link, Google Scholar 2. . Surgical outcomes from limiting the use of nonabsorbable suture in tunica albuginea plication for Peyronie's disease. Int J Impot Res.2017; 29(6):258-261. Crossref, Medline, Google Scholar 3. . Long-term outcomes after plaque excision grafting for Peyronie's disease and subanalysis of patients who undergo the procedure despite preoperative counseling against it. J Sex Med.2023; 21(2):163-168. Crossref, Google Scholar 4. . Plication for severe Peyronie's deformities has similar long-term outcomes to milder cases. J Sex Med.2018; 15(10):1498-1505. Crossref, Medline, Google Scholar 5. . Penile surgery for patients with Peyronie's disease initially treated with collagenase Clostridium histolyticum or surgery: a claims database analysis. Int J Impot Res.2023; 35(2):147-151. Crossref, Medline, Google Scholar 6. . A worldwide survey on Peyronie's disease surgical practice patterns among surgeons. J Sex Med.2018; 15(4):568-575. Crossref, Medline, Google Scholar 7. . An analysis of case logs from American urologists in the treatment of Peyronie's disease. Urology.2016; 87:205-209. Crossref, Medline, Google Scholar 8. . Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol.2013; 190(1):199-207. Link, Google Scholar 9. Long-term curvature deformity characterization in men previously treated with collagenase Clostridium histolyticum for Peyronie's disease, subgrouped by penile plaque calcification. Urology.2020; 146:145. Crossref, Medline, Google Scholar 10. . Efficacy of combined collagenase Clostridium histolyticum and RestoreX penile traction therapy in men with Peyronie's disease. J Sex Med.2019; 16(6):891-900. Crossref, Medline, Google Scholar 11. Improved Peyronie's disease curvature outcomes using a novel collagenase administration protocol. Urology. 2022; 170:117. Crossref, Medline, Google Scholar 12. . Treatment patterns and healthcare outcomes with collagenase Clostridium histolyticum vs surgery in Peyronie's disease: a retrospective claims database analysis. Sex Med.2021; 9(2):100321. Crossref, Medline, Google Scholar 13. . Self-reported clinical meaningfulness early in the treatment course predicts objective outcomes in men undergoing collagenase Clostridium histolyticum injections for Peyronie disease. Urology. 2017; 106:107. Crossref, Medline, Google Scholar © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Landon Trost More articles by this author Expand All Advertisement PDF downloadLoading ...